NEW YORK (Reuters Health) – Prophylactic antibiotics may improve survival of burn patients, a meta-analysis suggests, although the authors acknowledge that the quality of the supporting data is…
NEW YORK (Reuters Health) – Long-term treatment with clofazimine or nitroimidazoles may help control Crohn’s disease, according to the authors of a systematic review and meta-analysis. Several bacteria…
NEW YORK (Reuters Health) – Patients taking azathioprine or 6-mercaptopurine for inflammatory bowel disease (IBD) have more than a five-times higher risk of developing a lymphoproliferative disorder compared…
NEW YORK (Reuters Health) – In most patients with Crohn’s disease, endoscopic findings have relatively little impact on clinical decision making, results of a study conducted in Italy…
NEW YORK (Reuters Health) – Some modulators of 5-hydroxytryptamine (5-HT) appear to be effective in relieving symptoms of irritable bowel syndrome (IBS), the results of a systematic review…
CHICAGO (Reuters Health) – A Canadian study of patients with inflammatory bowel disease (IBD) shows that they are 42% more likely to acquire methicillin-resistant Staphylococcus aureus (MRSA) infections…
NEW YORK (Reuters Health) – Long-term treatment with infliximab has a good safety profile and significantly reduces hospitalization and surgery rates in patients with Crohn’s disease, according to…
John J. Huang, MD, Assistant Professor at the Yale Eye Center, discusses the etiologies causing uveitis. References and Resources Ephgrave K. Extra-intestinal manifestations of Crohn’s disease. Surg Clin…
NEW YORK (Reuters Health) – Elective repeat cesarean delivery at term but before 39 weeks is associated with higher rates of adverse outcomes, physicians in the US report…
John J. Huang, MD, Assistant Professor at the Yale Eye Center, talks about diagnosis and treatment of uveitis. References and Resources Ephgrave K. Extra-intestinal manifestations of Crohn’s disease.…
